All Articles

French real estate leader ARGAN unveils a new digital platform and a bold purpose, pioneering energy-independent warehouses that redefine the logistics industry.

A major marketing acquisition signals a new era for healthcare engagement, where immersive, data-driven experiences are becoming essential for building trust.

From AI-driven business to authentic cuisine and anti-swipe dating apps, a new leadership ethos is emerging. Here's how it's shaping our future.

Beyond the trophy, Lytx's third Company of the Year award reveals a deep strategy of AI, data, and human-centric design revolutionizing fleet safety.

A new partnership is bringing CPG-level data analytics to cannabis, promising to transform a fragmented market into a sophisticated, data-driven industry.

New data uncovers the shocking vet bills for common pet ingestions, from chocolate to socks. Discover how insurance insights are changing pet safety.

From AI-powered diagnostics to national health reforms, key industry shifts are redefining patient care. We dissect the innovations shaping the future of medicine.

An Inc. award reveals the blueprint for practical AI. See how a dual-model system solved a key industry problem, boosting engagement and creating revenue.

As CEOs demand a return to the office, one firm is using AI to make location a strategic tool for employee retention. Here's why it matters.

The plant nutrition expert is launching a new commercial division, betting on bulk formats and its first-ever soluble fertilizers to win large-scale growers.

As new privacy laws and AI risks loom, one firm's validated leadership in data intelligence is showing enterprises how to turn security into a strategic asset.

How one advisory firm's $100K Giving Tuesday grant reveals a deeper strategy of employee-led philanthropy and strategic brand building.

With a new CEO and private equity backing, Infotree Global Solutions is poised to conquer the complex world of international workforce management for F500 firms.

A study by The Farmer's Dog claimed big health benefits, but a scathing critique alleges flawed science, raising critical questions for pet owners.

Advisors drown in data while client time suffers. Milemarker's new Navigator AI promises a secure, custom intelligence engine to flip the script.

A regulatory filing reveals Balyasny's stake in Avadel Pharmaceuticals, exposing the high-stakes financial chess game behind a major narcolepsy drug.

Colorado's Alpine Bank offers to swap illiquid Class A shares for traded Class B stock, a strategic move to boost shareholder value and fortify its independence.

The strategic union of Pyxera Global and Common Impact creates a new powerhouse, poised to scale corporate purpose and bolster nonprofit resilience.

As multiple suitors vie for eyewear firm Inspecs, Downing LLP's disclosure of a 9.16% holding signals a new strategic player in a complex M&A battle.

LAMY's all-stock deal for Exousia AI is more than a merger; it's a strategic coup built on an early FDA designation for a novel brain cancer therapy.